How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy?

被引：0
|
作者：
Andrea V. Barrio
Anita Mamtani
Marcia Edelweiss
Anne Eaton
Michelle Stempel
Melissa P. Murray
Monica Morrow
机构：
[1] Memorial Sloan Kettering Cancer Center,Breast Service, Department of Surgery
[2] Memorial Sloan Kettering Cancer Center,Department of Pathology
[3] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
来源：
Annals of Surgical Oncology | 2016年 / 23卷
关键词：
Sentinel Node Biopsy; Axillary Lymph Node Dissection; Isosulfan Blue; Sentinel Node Biopsy Group; Regional Recurrence Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3475 / 3480
页数：5
相关论文
共 50 条
  • [31] Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
    Baron, Paul
    Beitsch, Peter
    Boselli, Danielle
    Symanowski, James
    Pellicane, James V.
    Beatty, Jennifer
    Richards, Paul
    Mislowsky, Angela
    Nash, Charles
    Lee, Laura A.
    Murray, Mary
    de Snoo, Femke A.
    Stork-Sloots, Lisette
    Gittleman, Mark
    Akbari, Stephanie
    Whitworth, Pat
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (05) : 1522 - 1529
  • [32] Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
    Paul Baron
    Peter Beitsch
    Danielle Boselli
    James Symanowski
    James V. Pellicane
    Jennifer Beatty
    Paul Richards
    Angela Mislowsky
    Charles Nash
    Laura A. Lee
    Mary Murray
    Femke A. de Snoo
    Lisette Stork-Sloots
    Mark Gittleman
    Stephanie Akbari
    Pat Whitworth
    Annals of Surgical Oncology, 2016, 23 : 1522 - 1529
  • [33] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
    Sari, E.
    Aksoy, S.
    Dogan, M.
    Altinbas, M.
    Zengin, N.
    Ozisik, Y.
    Altundag, K.
    BREAST, 2015, 24 : S99 - S99
  • [34] Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
    Choi, Hee Jun
    Ryu, Jai Min
    Lee, Jun Ho
    Bang, Yoonju
    Oh, Jongwook
    Chae, Byung-Joo
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Lee, Se Kyung
    Yu, Jonghan
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [35] Treatment effect in the breast and axillary lymph nodes predicts low axillary disease burden after neoadjuvant chemotherapy for breast cancer
    Hieken, T. J.
    Shah, S. S.
    Degnim, A. C.
    Jakub, J. W.
    Boughey, J. C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S132 - S132
  • [36] A model to predict axillary nodal pathologic complete response following neoadjuvant chemotherapy for breast cancer.
    Kantor, Olga
    McNulty, Lynn
    Yao, Katharine
    James, Ted A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Prognostic significance of residual micrometastatic axillary involvement with complete pathologic breast response after neoadjuvant chemotherapy for early breast cancer
    Garcia-Torralba, Esmeralda
    Guirao Garcia, Maria Esperanza
    de la Morena Barrio, Pilar
    Ivars Rubio, Alejandra
    Garcia Martinez, Elena
    Garcia Garre, Elisa
    Marin Zafra, Gema
    Alvarez Abril, Beatriz
    Navarro Manzano, Esther
    Ayala de la Pena, Francisco
    CANCER RESEARCH, 2021, 81 (04)
  • [38] The Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer
    Lim, David W.
    Greene, Brittany D.
    Hong, Nicole Look
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S201 - S201
  • [39] Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer
    Lim, David W.
    Greene, Brittany D.
    Look Hong, Nicole J.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (10) : 5495 - 5506
  • [40] Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer
    David W. Lim
    Brittany D. Greene
    Nicole J. Look Hong
    Annals of Surgical Oncology, 2021, 28 : 5495 - 5506
12345